Vitacel

Developer of patented personalized cell technologies for skin therapy and periodontal soft tissue restoration using fibroblasts.

Vitacel LLC is a developer of cellular and tissue engineering technologies for regenerative medicine.

SPRS Therapy is an innovative proprietary medical technology of using one’s own dermal fibroblasts to correct age-related and scar skin defects. “Skin Passport” is unique personalized diagnostics of the regenerative and proliferative potential of the fibroblast population in the patient’s skin. SPRG Therapy is a medical technology for the restoration of soft periodontal tissues using autologous gingival dermal fibroblasts.

The technology is protected by Russian and international patents.

Subsidiary
www.sprs-therapy.ru

Vadim Zorin
CEO LLC «Skincel»

SPRS

Services for medical centers on the use of medical technology of autologous dermal fibroblasts for the correction of age-related and scarring skin defects

Service
Indication
Development
Validation
Licensing
Market
  • SPRS®-therapy
    Indication:
    Cellular skin correction
    Indication:

    Cellular skin correction

    Stage:
    Market
    Description:

    Innovative proprietary medical technology of using one’s own dermal fibroblasts to correct age-related and scar skin defects.

    Synthesizing collagen, elastin, hyaluronic acid, and other components of the intercellular matrix, fibroblasts effectively restore the microstructure of the skin and stimulate the natural processes of its renewal.

  • Skin Passport
    Indication:
    Skin condition diagnosis
    Indication:

    Skin condition diagnosis

    Stage:
    Market
    Description:

    Unique personalized diagnostics of the regenerative and proliferative potential of the fibroblast population in the patient’s skin. Modern laboratory techniques make it possible to assess the quantity and morphology of the fibroblasts available in the skin, as well as their functional division ability.

    An individual program is created for the patient to correct defects and prevent skin aging, also using cell therapy.

  • SPRG
    Indication:
    Restoration of periodontal tissues
    Indication:

    Restoration of periodontal tissues

    Stage:
    Licensing
    Description:

    Innovative medical technology for the restoration of soft periodontal tissues using autologous gingival dermal fibroblasts.

Developer: Skincel Vitacel